The 2025 review highlights the top 10 papers in thrombosis and antithrombotic therapy, summarizing findings that refine clinical practice and explore new developments.
Top 10 papers in 2025 on thrombosis and antithrombotic therapy. Several findings refine clinical practice (TARGET-FIRST, NEO-MINDSET, TACSI, AQUATIC, and COMBINE-AF); other investigations explore new developments (CELEBRATE, PRESTIGE-AF, ENBALV) and valve thrombosis management, or highlight unmet needs (ROPAC III). “” indicates “significant increase in rates of”.
Andreotti et al. (Sat,) conducted a review in Thrombosis and antithrombotic therapy. Antithrombotic therapy was evaluated. The 2025 review highlights the top 10 papers in thrombosis and antithrombotic therapy, summarizing findings that refine clinical practice and explore new developments.